FDMT 4D Molecular Therapeutics, Inc.
Price Chart
Executive Summary
The SEC declared effective 4D Molecular Therapeutics' S-3 shelf registration (File No. 333-295650) on May 13, 2026, allowing the company to sell up to $400M in securities. The shelf replaces a prior expiring facility with $200M carried forward and $200M newly registered. With $458M cash on hand and runway into H2 2028, no immediate offering is expected, but the large size relative to the $546M market cap creates a persistent dilution overhang.
Actionable Insight
Monitor for any takedown announcement under the shelf, which would signal near-term dilution. The company's strong cash position suggests no urgency, but the shelf size relative to market cap means any offering could be meaningfully dilutive. Watch for clinical catalysts that could trigger capital needs.
Key Facts
- Shelf registration (S-3) declared effective May 13, 2026
- Total shelf size: $400M ($200M carried forward + $200M newly registered)
- Company had $458M cash and runway into H2 2028 as of the prior S-3 filing
- No concurrent offering announced; shelf provides flexibility for future capital raises
Financial Impact
Potential dilution of up to ~73% of current market cap ($400M shelf vs $546M market cap) if fully utilized
Risk Factors
- Future offering under the shelf could dilute existing shareholders significantly
- Large shelf relative to market cap may overhang the stock even without an offering
- Clinical-stage biotech may need to access capital markets if pipeline milestones are delayed
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001626 |
| Document: 9999999995-26-001626-index.html | 9999999995-26-001626 |
| Document: 9999999995-26-001626.txt | 9999999995-26-001626 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 14, 2026
4w ago
|
EFFECT
| $9.81 $8.69 | ▼ −11.42% | ▼ −10.70% | $8.83 (−9.99%) |
|
May 7, 2026
5w ago
|
S-3
| $10.14 $9.81 | ▼ −3.25% | ▼ −4.72% | $8.83 (−12.92%) |
|
Mar 18, 2026
12w ago
|
Press Release
| $8.98 $10.18 | ▲ +13.36% | ▲ +15.57% | $8.83 (−1.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access